Richard P Hamel

Richard P. Hamel is a seasoned finance executive with extensive experience in leadership roles across various organizations. Currently serving as the Chief Financial Officer at Vernal Biosciences since October 2023, Richard previously held the same position at Arranta Bio from September 2022 to October 2023 and UBC from March 2018 to September 2022. Richard's career includes significant roles at inVentiv Health as VP Finance and VP Controller, as well as positions at Aptuit, Thermo Fisher Scientific, Kodak Polychrome Graphics, Volvo Financial Services, and Diageo. Richard holds an MBA from Union College and a BA (HON) from York University.